Aldeyra Stock Today
| ALDX Stock | USD 3.91 0.02 0.51% |
Performance7 of 100
| Odds Of DistressLess than 10
|
Aldeyra is trading at 3.91 as of the 24th of April 2024; that is -0.51 percent down since the beginning of the trading day. The stock's open price was 3.93. Aldeyra has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Aldeyra are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of May 2014 | Category Healthcare | Classification Health Care |
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts. Aldeyra Therapeu operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 58.9 M outstanding shares of which 2.05 M shares are presently shorted by private and institutional investors with about 3.86 trading days to cover. More on Aldeyra
Moving against Aldeyra Stock
| 0.73 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.63 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
| 0.53 | PCRX | Pacira Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.5 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.43 | GNTA | Genenta Science SpA Downward Rally | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Aldeyra Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aldeyra's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aldeyra or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Todd Brady | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Aldeyra report their recommendations after researching Aldeyra's financial statements, talking to executives and customers, or listening in on Aldeyra's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Aldeyra. The Aldeyra consensus assessment is calculated by taking the average forecast from all of the analysts covering Aldeyra. | ||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Aldeyra's financial statements, Aldeyra may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Aldeyra is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||
Aldeyra's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aldeyra's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aldeyra's financial leverage. It provides some insight into what part of Aldeyra's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Aldeyra (ALDX) is traded on NASDAQ Exchange in USA. It is located in 131 Hartwell Avenue, Lexington, MA, United States, 02421 and employs 10 people. Aldeyra is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 231.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aldeyra's market, we take the total number of its shares issued and multiply it by Aldeyra's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aldeyra conducts business under Biotechnology sector and is part of Health Care industry. The entity has 58.9 M outstanding shares of which 2.05 M shares are presently shorted by private and institutional investors with about 3.86 trading days to cover.
Aldeyra currently holds about 163.83 M in cash with (30.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.8.
Check Aldeyra Probability Of Bankruptcy
Ownership AllocationAldeyra retains a total of 58.9 Million outstanding shares. Over half of Aldeyra's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Aldeyra. Please watch out for any change in the institutional holdings of Aldeyra as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Aldeyra Ownership Details
Aldeyra Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Aldeyra jumping above the current price in 90 days from now is about 20.51%. The Aldeyra probability density function shows the probability of Aldeyra stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.793. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aldeyra will likely underperform. Additionally, aldeyra has an alpha of 0.2863, implying that it can generate a 0.29 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Aldeyra to move above the current price in 90 days from now is about 20.51 (This Aldeyra probability density function shows the probability of Aldeyra Stock to fall within a particular range of prices over 90 days) .
Aldeyra Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Aldeyra that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aldeyra's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aldeyra's value.| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2023-12-31 | 440.4 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 420.1 K | |
| Northern Trust Corp | 2023-12-31 | 393 K | |
| Bank Of America Corp | 2023-12-31 | 373.9 K | |
| Two Sigma Advisers, Llc | 2023-12-31 | 351.4 K | |
| Wells Fargo & Co | 2023-12-31 | 345.1 K | |
| Renaissance Technologies Corp | 2023-12-31 | 300 K | |
| Johnson & Johnson | 2023-12-31 | 299.7 K | |
| Deutsche Bank Ag | 2023-12-31 | 297.4 K | |
| Perceptive Advisors Llc | 2023-12-31 | 8.6 M | |
| Knoll Capital Management Lp | 2023-12-31 | 5.5 M |
Aldeyra Historical Income Statement
Aldeyra Income Statement is one of the three primary financial statements used for reporting Aldeyra's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aldeyra revenue and expense. Aldeyra Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Aldeyra's Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 5.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 249.6 K in 2024. View More FundamentalsAldeyra Stock Against Markets
Picking the right benchmark for Aldeyra stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aldeyra stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aldeyra is critical whether you are bullish or bearish towards Aldeyra at a given time. Please also check how Aldeyra's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aldeyra without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Aldeyra Corporate Directors
Aldeyra corporate directors refer to members of an Aldeyra board of directors. The board of directors generally takes responsibility for the Aldeyra's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Aldeyra's board members must vote for the resolution. The Aldeyra board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gary Phillips | Independent Director | Profile | |
| Martin Joyce | Independent Director | Profile | |
| Ben Bronstein | Director | Profile | |
| Neal Walker | Independent Director | Profile |
How to buy Aldeyra Stock?
Before investing in Aldeyra, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Aldeyra. To buy Aldeyra stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Aldeyra. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Aldeyra stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Aldeyra stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Aldeyra stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Aldeyra, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.
Already Invested in Aldeyra?
The danger of trading Aldeyra is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aldeyra is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aldeyra. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aldeyra is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aldeyra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aldeyra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aldeyra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aldeyra Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aldeyra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.Note that the Aldeyra information on this page should be used as a complementary analysis to other Aldeyra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Aldeyra Stock analysis
When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Aldeyra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aldeyra. If investors know Aldeyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aldeyra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Return On Assets (0.16) | Return On Equity (0.28) |
The market value of Aldeyra is measured differently than its book value, which is the value of Aldeyra that is recorded on the company's balance sheet. Investors also form their own opinion of Aldeyra's value that differs from its market value or its book value, called intrinsic value, which is Aldeyra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aldeyra's market value can be influenced by many factors that don't directly affect Aldeyra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aldeyra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aldeyra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aldeyra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.